These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1848107)

  • 1. Evidence that a protein kinase enhances amsacrine mediated formation of topoisomerase II-DNA complexes in murine mastocytoma cell nuclei.
    Darkin-Rattray SJ; Ralph RK
    Biochim Biophys Acta; 1991 Feb; 1088(2):285-91. PubMed ID: 1848107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of topoisomerase II by murine mastocytoma cells.
    Collett AG; Ralph RK
    Biochim Biophys Acta; 1992 Oct; 1132(3):259-64. PubMed ID: 1329975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protein factor that enhances amsacrine-mediated formation of topoisomerase II-DNA complexes in murine mastocytoma cell nuclei.
    Darkin SJ; Ralph RK
    Biochim Biophys Acta; 1989 Apr; 1007(3):295-300. PubMed ID: 2539190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that mAMSA induces topoisomerase action.
    Marshall B; Darkin S; Ralph RK
    FEBS Lett; 1983 Sep; 161(1):75-8. PubMed ID: 6309576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between sensitivity to 4'-(9-acridinylamino)methanesulfon-m-anisidide and DNA topoisomerase II in a cold-sensitive cell-cycle mutant of a murine mastocytoma cell line.
    Schneider E; Hutchins AM; Darkin SJ; Lawson PA; Ralph RK
    Biochim Biophys Acta; 1988 Nov; 951(1):85-97. PubMed ID: 2847799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    Lelièvre S; Benchokroun Y; Larsen AK
    Mol Pharmacol; 1995 May; 47(5):898-906. PubMed ID: 7746278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
    Pommier Y; Orr A; Kohn KW; Riou JF
    Cancer Res; 1992 Jun; 52(11):3125-30. PubMed ID: 1317259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.
    Zwelling LA; Slovak ML; Doroshow JH; Hinds M; Chan D; Parker E; Mayes J; Sie KL; Meltzer PS; Trent JM
    J Natl Cancer Inst; 1990 Oct; 82(19):1553-61. PubMed ID: 1976136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation.
    Corbett AH; Fernald AW; Osheroff N
    Biochemistry; 1993 Mar; 32(8):2090-7. PubMed ID: 8383533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.
    Zwelling LA; Mitchell MJ; Satitpunwaycha P; Mayes J; Altschuler E; Hinds M; Baguley BC
    Cancer Res; 1992 Jan; 52(1):209-17. PubMed ID: 1309224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of DNA topoisomerase II in vivo and in total homogenates of Drosophila Kc cells. The role of casein kinase II.
    Ackerman P; Glover CV; Osheroff N
    J Biol Chem; 1988 Sep; 263(25):12653-60. PubMed ID: 2842338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
    Per SR; Mattern MR; Mirabelli CK; Drake FH; Johnson RK; Crooke ST
    Mol Pharmacol; 1987 Jul; 32(1):17-25. PubMed ID: 3037302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei.
    Gromova II; Thomsen B; Razin SV
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):102-6. PubMed ID: 7816796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistance.
    Hill BT; Whelan RD; Hosking LK; Shellard SA; Hinds MD; Mayes J; Zwelling LA
    Int J Cancer; 1991 Apr; 47(6):899-902. PubMed ID: 1849124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular molecular interactions of antitumor drug amsacrine (m-AMSA) as revealed by surface-enhanced Raman spectroscopy.
    Chourpa I; Morjani H; Riou JF; Manfait M
    FEBS Lett; 1996 Nov; 397(1):61-4. PubMed ID: 8941714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide.
    DeVore RF; Corbett AH; Osheroff N
    Cancer Res; 1992 Apr; 52(8):2156-61. PubMed ID: 1313738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine.
    Baguley BC; Leteurtre F; Riou JF; Finlay GJ; Pommier Y
    Eur J Cancer; 1997 Feb; 33(2):272-9. PubMed ID: 9135499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered phosphorylation, biosynthesis and degradation of the 170 kDa isoform of topoisomerase II in amsacrine-resistant human leukemia cells.
    Ganapathi R; Zwelling L; Constantinou A; Ford J; Grabowski D
    Biochem Biophys Res Commun; 1993 May; 192(3):1274-80. PubMed ID: 8389546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topological complexes between DNA and topoisomerase II and effects of polyamines.
    Pommier Y; Kerrigan D; Kohn K
    Biochemistry; 1989 Feb; 28(3):995-1002. PubMed ID: 2540827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.